Sinead Delany-Moretlwe

Summary

Affiliation: Reproductive Health and HIV Research Unit
Country: South Africa

Publications

  1. ncbi Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa
    Sinead Delany
    Reproductive Health and HIV Research Unit, University of Witwatersrand, Johannesburg, Republic of South Africa
    AIDS 23:461-9. 2009
  2. ncbi Using research to influence sexual and reproductive health practice and implementation in Sub-Saharan Africa: a case-study analysis
    Olivia Tulloch
    International Health Research Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK
    Health Res Policy Syst 9:S10. 2011
  3. ncbi Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions
    Sinead Delany
    Reproductive Health and HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 49:406-9. 2008
  4. ncbi Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population
    Sinead Delany-Moretlwe
    Reproductive Health and HIV Research Unit, University of the Witwatersrand, PO Box 18512, Hillbrow, Johannesburg 2038, South Africa
    Sex Transm Infect 86:46-50. 2010
  5. ncbi Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South Africa
    Sinead Delany-Moretlwe
    Reproductive Health and HIV Research Unit, University of the Witwatersrand, South Africa
    Health Res Policy Syst 9:S8. 2011

Collaborators

Detail Information

Publications5

  1. ncbi Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa
    Sinead Delany
    Reproductive Health and HIV Research Unit, University of Witwatersrand, Johannesburg, Republic of South Africa
    AIDS 23:461-9. 2009
    ..Several studies suggest that herpes simplex virus type 2 (HSV-2) may enhance HIV-1 transmission and disease progression...
  2. ncbi Using research to influence sexual and reproductive health practice and implementation in Sub-Saharan Africa: a case-study analysis
    Olivia Tulloch
    International Health Research Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK
    Health Res Policy Syst 9:S10. 2011
    ..Policy issues in SRH can be controversial, influenced by political factors and shaped by context such as religion, ethnicity, gender and sexuality...
  3. ncbi Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions
    Sinead Delany
    Reproductive Health and HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    J Acquir Immune Defic Syndr 49:406-9. 2008
    ....
  4. ncbi Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population
    Sinead Delany-Moretlwe
    Reproductive Health and HIV Research Unit, University of the Witwatersrand, PO Box 18512, Hillbrow, Johannesburg 2038, South Africa
    Sex Transm Infect 86:46-50. 2010
    ..The performance of two widely used gG2 ELISA was compared to derive an appropriate testing algorithm for use in South Africa...
  5. ncbi Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South Africa
    Sinead Delany-Moretlwe
    Reproductive Health and HIV Research Unit, University of the Witwatersrand, South Africa
    Health Res Policy Syst 9:S8. 2011
    ..Communicating the results of randomised controlled trials may present challenges for researchers who have to work with communities and policy-makers to anticipate positive outcomes, while being aware that results may show no effect or harm...